[1]张军.11C-flumazenil受体显像在缺血半暗带研究中的进展[J].国际放射医学核医学杂志,2004,28(6):246-249.
　ZHANG Jun.Advances of 11C-flumazenil receptor imaging in ischemic penumbra[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(6):246-249.
点击复制

11C-flumazenil受体显像在缺血半暗带研究中的进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
28
期数:
2004年第6期
页码:
246-249
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Advances of 11C-flumazenil receptor imaging in ischemic penumbra
作者:
张军
430022 武汉, 华中科技大学同济医学院附属协和医院核医学科
Author(s):
ZHANG Jun
Department of Nuclear Medicine, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
关键词:
缺血半暗带; 正电子发射体层显像; 11C-flumazenil; 受体显像
Keywords:
ischemic penumbra; positron emission tomography; 11C-flumazenil; receptor imaging
分类号:
R817.4
摘要:
缺血半暗带是缺血性卒中的治疗目标,故而研究出一种早期精确判定脑组织活性的显像方法极为重要。PET神经受体显像,尤其是11C-flumazenil受体显像不仅可早期鉴别神经元的功能性或形态性损伤,将不可逆性损伤组织与半暗带区分开来,还可预测脑梗死的恶性病程,从而有助于介入治疗病例的选择及正确治疗策略的制订。
Abstract:
The ischemic penumbra is the target of therapy for ischemic stroke patients, so it is extremely important to investigate an imaging technique that may identify accurately the viability of cerebral tissues early. The neuroreceptor imaging with positron emission tomography has achieved some successes in this study field, in particular, the 11C-flumazenil receptor imaging, which can not only differentiate between the neurons of functional impairment and those of morphological destruction, and then distinguish the is-chemic penumbra from the irreversible damage tissues, but predict the malignant course of cerebral infarction. Consequently, these will help to select the patients benefiting from the intervention therapy and plan effectively the therapeutic strategies.

参考文献/References:

1 Heiss WD.Best measure of ischemic penumbra:positron emission tomography[J].Stroke,2003,34(10):2534-2535.
2 Heiss WD,Grond M,Thiel A,et al.Tissue at risk of infarction rescued by early reperfusion:a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke[J].J Cereb Blood Flow Metab,1998,18(12):1298-1307.
3 Warach S.Measurement of the ischemic penumbra with MRI:it’s about time[J].Stroke,2003,34(10):2533-2534.
4 Sette G,Baron JC,Young AR,et al.In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon[J].Stroke,1993,24(12):2046-2057.
5 Heiss WD,Graf R,Fujita T,et al.Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats[J].Stroke,1997,28(10):2045-2051.
6 Heiss WD,Grond M,Thiel A,et al.Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke[J].Stroke,1998,29(2):454-461.
7 Heiss WD,Kracht L,Grond M,et al.Early[11C] Flumazenil/H2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy[J].Stroke,2000,31(2):366-369.
8 Heiss WD,Kracht LW,Thiel A,et al.Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia[J].Brain,2001,124(1):20-29.
9 Dohmen C,Bosche B,Graf R,et al.Prediction of malignant course in MCA infarction by PET and microdialysis[J].Stroke,2003,34(9):2152-2158.
10 Grunder G,Siessmeier T,Lange-Asschenfeldt C,et al.[18F]Fluo-roethyl-flumazenil:a novel tracer for PET imaging of human benzodiazepine receptors[J].Eur J Nucl Med,2001,28(10):1463-1470.
11 Nakagawara J,Sperling B,Lassen NA.Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil[J].Stroke,1997,28(1):124-132.
12 Nariai T,Shimada Y,Ishiwata K,et al.PET imaging of adenosine A1 receptors with 11C-MPDX as an indicator of severe cerebral ischemic insult[J].J Nucl Med,2003,44(11):1839-1844.
13 Ishiwata K,Nariai T,Kimura Y,et al.Preclinical studies on[11C] MPDX for mapping adenosine A1 receptors by positron emission tomography[J].Ann Nucl Med,2002,16(6):377-382.
14 Fukumitsu N,Ishii K,Kimura Y,et al.Imaging of adenosine A1 receptors in the human brain by positron emission tomography with[11C] MPDX[J].Ann Nucl Med,2003,17(6):511-515.

相似文献/References:

[1]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
　ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):1.
[2]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
　CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):10.
[3]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
　DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):148.
[4]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
　JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):197.
[5]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
　CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):201.
[6]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
　WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):205.
[7]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
　DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):209.
[8]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
　LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):213.
[9]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
　HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):216.
[10]黎海涛.PET-CT在乳腺癌诊断中的应用价值[J].国际放射医学核医学杂志,2005,29(5):220.
　LI Hai-tao.The application value of PET-CT in the diagnosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):220.

备注/Memo

备注/Memo:
收稿日期:2004-04-11。
更新日期/Last Update: 1900-01-01